Amron Arthur H 4

What Happened

• Amron Arthur H, a director of NEPHROS Inc. (NEPH), was issued 3,610 shares on 2026-03-16 as a grant/award. The shares were reported at $0.00 per share, indicating they were issued in lieu of cash board fees (footnote F1). This is a compensation issuance rather than an open-market purchase or sale.

Key Details

• Transaction date and price: 2026-03-16, 3,610 shares @ $0.00 (issued as fees).
• Filing date: Form 4 filed 2026-03-18 (covers the 3/16 transaction).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes: F1 — shares issued in lieu of cash fees for board service. F2/F3 — reference separate option grants with vesting schedules (2,441 shares vesting 5/14/24, 5/14/25, 5/14/26; and 2,350 shares vesting 1/1/25, 1/1/26, 1/1/27).
• Timeliness: Filing appears timely (filed two days after the transaction).

Context

• This was an award/compensation issuance, not a purchase; such issuances are routine for non-employee directors and do not necessarily indicate the director is buying or selling based on company outlook. The footnotes indicate the insider also has option grants with scheduled vesting, but there is no indication in this report of option exercises or immediate sales of the newly issued shares.